Successful private placement and retail offering - Zelluna ASA raises NOK 58 million to advance the world’s first 'off-the-shelf” TCR-NK therapy, ZI-MA4-1, into Phase I clinical trials and develop the ...

Pet owners, be aware! Diabetes in dogs is common and early signs are crucial for management. Look out for increased thirst, ...

The global sports betting market has undergone a dramatic transformation in recent years, driven by rapid technological ...

Tech’s renewed appetite for nuclear energy is reshaping the market – and Australian explorers operating in the US stand to ...

The Cadillac CT6 almost feels like a distant memory now, but at one point, it was GM's ambitious attempt to take on the dominant luxury flagships that had been eating Cadillac's lunch for decades. It ...

Government hiring data is on hold during the shutdown, but earlier this month a survey by payroll company ADP showed a ...

A new era will begin for one of Sydney's most iconic heritage buildings on 2nd February 2026 with the opening of The Lands by ...

Shares in the US technology giant rose another 6% to $259 in early trading in New York following a near-10% jump on Friday.

Karyopharm Therapeutics Inc. , a commercial-stage pharmaceutical company pioneering novel cancer therapies, today reported financial results for the third quarter ended September 30, 2025 and ...

Q3 2025 Earnings Call October 29, 2025 9:30 AM EDTCompany ParticipantsStephen Vather - Vice President of Investor Relations ...

Advanced Innergy has a strong competitive moat with 181 patents and 93 type approvals that would take new entrants years and ...